Idexx Laboratories (IX1) Revenue
Idexx Laboratories Revenue
Idexx Laboratories had a revenue of 1.22B in the quarter ending Jun 30, 2026, with 6.64%. This bring the company's revenue in the last twelve months to 4.55B, Increased 2.41%. In the fiscal year ending Dec 31, 2025, Idexx Laboratories had annual revenue of 4.30B with 10.42% growth.
- Revenue (ttm)
- 4.55B
- Revenue Growth
- 5.23%
- P/S Ratio
- 9.00
- Revenue/Employee
- EUR 391,246
- Employees
- 11,000
- Market Cap
- EUR 38.75B
Revenue Chart
Idexx Laboratories Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.30B | 406.20M | 10.42% |
| Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
| Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
| Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
| Dec 31, 2021 | 3.22B | 508.70M | 18.79% |
| Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
| Dec 31, 2019 | 2.41B | 193.67M | 8.75% |
| Dec 31, 2018 | 2.21B | 244.18M | 12.40% |
| Dec 31, 2017 | 1.97B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.